Kragh-Sørensen P, Overø K F, Petersen O L, Jensen K, Parnas W
Acta Pharmacol Toxicol (Copenh). 1981 Jan;48(1):53-60. doi: 10.1111/j.1600-0773.1981.tb01587.x.
The kinetics of citalopram were studied in a group of volunteers after oral (8 subjects) and intravenous (4 subjects) single doses and repeated oral administration (7 subjects). Inter- and intraindividual variation was limited and linearity of kinetics indicated. Systemic and apparent oral clearance estimates (mean 0.42 l plasma/min.) were similar, indicating roughly complete systemic availability. The presence of unchanged drug in urine, corresponding to 1/7 of the dose, suggests elimination by renal as well as hepatic processes. The data from the intravenous test revealed two compartment kinetics; the total volume of distribution was estimated to about 1150 l and that of the central compartment to 175 l. Upon repeated administration steady-state conditions were generally achieved after one week in agreement with the 33 hrs half-life of elimination. Citalopram peak concentrations were reached within 2-4 hours after the daily dose and maximally two-fold variation was recorded in the 24 hrs dose interval. The levels of a main pharmacodynamically active metabolite were roughly half as high as the drug levels.
在一组志愿者中研究了西酞普兰的动力学,这些志愿者接受了单次口服(8名受试者)、单次静脉注射(4名受试者)以及多次口服给药(7名受试者)。个体间和个体内差异有限,表明动力学呈线性。全身清除率和表观口服清除率估计值(平均0.42升血浆/分钟)相似,表明全身可用性大致完全。尿中存在未变化的药物,相当于剂量的1/7,提示通过肾脏和肝脏过程进行消除。静脉注射试验的数据显示为二室动力学;分布总体积估计约为1150升,中央室体积为175升。多次给药后,与33小时的消除半衰期一致,通常在一周后达到稳态。每日剂量后2 - 4小时达到西酞普兰峰值浓度,在24小时剂量间隔内记录到的最大变化为两倍。一种主要的药效学活性代谢物的水平约为药物水平的一半。